Article
Translating complexity and heterogeneity of pancreatic tumor: 3D in vitro to in vivo models
23 Apr 2021
Abstract excerpt
Pancreatic ductal adenocarcinoma (PDAC) is an extremely aggressive type of cancer with an overall survival rate of less than 7-8%, emphasizing the need for novel effective therapeutics against PDAC. However only a fraction of therapeutics which seemed promising in the laboratory environment will eventually reach the clinic. One of the main reasons behind this low success rate is the complex tumor microenvironment...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
